Drugs / CCR5 gene modification
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03164135 | May 2017 → May 2019 | HIV infectious disease | Affiliated Hospital to Academy of Military Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CCR5 gene modification | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03164135 ↗ |
| Action | Inhibit | “to ablate CCR5 gene” NCT03164135 ↗ |
| Modality | CRISPR / gene editing | “treated with CRISPR/Cas9” NCT03164135 ↗ |
| Target | CCR5 | “targeting CCR5 gene” NCT03164135 ↗ |